USP2 and breast cancer: Another recent study explored the cuproptosis-related prognostic 2-lncRNAs (USP2- AS1, NIFK-AS1) signature (BCCuS) in breast cancer and validated it as an independent prognostic factor for breast cancer (Xu Q. T. et al., 2022).